Harada Jun, Nakajima Takeshi, Kanazawa Nobuo
Department of Dermatology, Osaka General Medical Center of Medicine, Osaka, Japan.
Department of Dermatology, Wakayama Medical University, Wakayama, Japan.
Pediatr Dermatol. 2016 Nov;33(6):e385-e387. doi: 10.1111/pde.12908. Epub 2016 Jun 24.
We report a 3.5-year-old Japanese boy who developed lichenoid papules and erythema with noncaseating epithelioid cell granulomas with a scant lymphocytic infiltrate histologically on his limbs at the age of 8 months. Genetic analysis of the patient and his parents, who had no medical past history, revealed heterozygous 1147G>A (E383K) mutation of NOD2 in the patient and in his father, so the patient was diagnosed with Blau syndrome and his father as an asymptomatic carrier. Although Blau syndrome has been reported as a genetic disease with high penetrance, asymptomatic carrier cases of a family with the same E383K mutation have also been reported. These results suggest that some contributing factors are required for the development of inflammatory and granulomatous responses in heterozygous carriers of a NOD2 E383K mutation.
我们报告一名3.5岁的日本男孩,他在8个月大时四肢出现苔藓样丘疹和红斑,组织学检查显示有非干酪样上皮样细胞肉芽肿,淋巴细胞浸润稀少。对该患者及其无病史的父母进行基因分析,发现患者及其父亲的NOD2基因存在杂合1147G>A(E383K)突变,因此该患者被诊断为布劳综合征,其父亲为无症状携带者。虽然布劳综合征已被报道为一种高外显率的遗传病,但也有报道称同一家庭中存在具有相同E383K突变的无症状携带者病例。这些结果表明,NOD2 E383K突变杂合携带者发生炎症和肉芽肿反应需要一些促成因素。